Nothing Special   »   [go: up one dir, main page]

DK499477A - Anvendelse af ergotpeptidalkaloid-praeparat - Google Patents

Anvendelse af ergotpeptidalkaloid-praeparat

Info

Publication number
DK499477A
DK499477A DK499477A DK499477A DK499477A DK 499477 A DK499477 A DK 499477A DK 499477 A DK499477 A DK 499477A DK 499477 A DK499477 A DK 499477A DK 499477 A DK499477 A DK 499477A
Authority
DK
Denmark
Prior art keywords
kaloid
ergotpeptidal
preparation
kaloid preparation
ergotpeptidal kaloid
Prior art date
Application number
DK499477A
Other languages
English (en)
Other versions
DK153440C (da
DK153440B (da
Inventor
M Azria
T Cavanak
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK499477A publication Critical patent/DK499477A/da
Publication of DK153440B publication Critical patent/DK153440B/da
Application granted granted Critical
Publication of DK153440C publication Critical patent/DK153440C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01DMEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
    • G01D2207/00Indexing scheme relating to details of indicating measuring values
    • G01D2207/10Displays which are primarily used in aircraft or display aircraft-specific information

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK499477A 1976-11-19 1977-11-10 Fremgangsmaade til fremstilling af et nasalt farmaceutisk ergotpeptidalkaloid-praeparat DK153440C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1457576 1976-11-19
CH1457576 1976-11-19
CH698977 1977-06-07
CH698977 1977-06-07

Publications (3)

Publication Number Publication Date
DK499477A true DK499477A (da) 1978-05-20
DK153440B DK153440B (da) 1988-07-18
DK153440C DK153440C (da) 1989-01-02

Family

ID=25700540

Family Applications (1)

Application Number Title Priority Date Filing Date
DK499477A DK153440C (da) 1976-11-19 1977-11-10 Fremgangsmaade til fremstilling af et nasalt farmaceutisk ergotpeptidalkaloid-praeparat

Country Status (27)

Country Link
US (2) US4462983A (da)
JP (1) JPS5366440A (da)
AT (1) AT368881B (da)
AU (1) AU520754B2 (da)
CA (1) CA1103585A (da)
CS (2) CS228502B2 (da)
CY (1) CY1266A (da)
DE (2) DE2750090A1 (da)
DK (1) DK153440C (da)
ES (1) ES464275A1 (da)
FI (1) FI773376A (da)
FR (1) FR2371454A1 (da)
GB (1) GB1592563A (da)
GR (1) GR65229B (da)
HK (1) HK85984A (da)
HU (1) HU185924B (da)
IE (1) IE46167B1 (da)
IL (1) IL53419A (da)
KE (1) KE3453A (da)
MY (1) MY8400055A (da)
NL (1) NL187892C (da)
NO (1) NO773839L (da)
NZ (1) NZ185711A (da)
PH (1) PH23643A (da)
PT (1) PT67292B (da)
SE (1) SE451944B (da)
SG (1) SG61784G (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
US4284648A (en) * 1979-08-03 1981-08-18 The University Of Kentucky Research Foundation Nasal administration of propranolol
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
FI81258C (fi) * 1982-02-01 1990-10-10 Sandoz Ag Foerfarande foer framstaellning av en farmaceutisk komposition foer nasal administration.
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
GB8413795D0 (en) * 1984-05-30 1984-07-04 Sandoz Ltd Organic compounds
GB8426922D0 (en) * 1984-10-24 1984-11-28 Sandoz Ltd Galenic formulation
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
FR2628638B1 (fr) * 1985-03-06 1992-12-18 Sandoz Lab Dispositif de pulverisation par voie nasale d'une dose unitaire de medicament en solution
JPS61263918A (ja) * 1985-05-16 1986-11-21 Banyu Pharmaceut Co Ltd 経皮吸収用製剤
DE3686025T2 (de) * 1985-05-22 1993-01-07 Liposome Technology Inc Verfahren und system zum einatmen von liposomen.
CA1291036C (en) * 1986-04-23 1991-10-22 Edwin I. Stoltz Nasal administration of drugs
US4782047A (en) * 1986-05-22 1988-11-01 Syntex Pharmaceuticals International Ltd. Aqueous steroid formulations for nasal administration
US4897256A (en) * 1986-11-25 1990-01-30 Abbott Laboratories LHRH analog formulations
DE3710216A1 (de) * 1987-03-27 1988-10-06 Rentschler Arzneimittel Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen
GB2216794B (en) * 1988-03-22 1991-11-20 Fisons Plc Pharmaceuticals compositions
US4929640A (en) * 1988-04-04 1990-05-29 George D. McAdory Medicaments intended for combined use in the improvement of lymphocyte function
GB2237510B (en) * 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration
IT1247472B (it) * 1991-05-31 1994-12-17 Fidia Spa Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
ATE222754T1 (de) * 1992-06-12 2002-09-15 Teijin Ltd Ultrafeines pulver zur inhalation und dessen herstellung
DE69330672T2 (de) * 1992-06-12 2002-06-27 Teijin Ltd., Osaka Pharmazeutische zubereitung zur anwendung in den atemwegen
ES2194867T3 (es) * 1993-03-26 2003-12-01 Franciscus Wilhelmus He Merkus Composiciones farmaceuticas para la administracion intranasal de apomorfina.
US6794357B1 (en) 1993-06-24 2004-09-21 Astrazeneca Ab Compositions for inhalation
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US5830853A (en) 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
US20010003739A1 (en) * 1993-06-24 2001-06-14 Astrazeneca Ab Systemic administration of a therapeutic preparation
US6932962B1 (en) 1994-12-22 2005-08-23 Astrazeneca Ab Aerosol drug formulations containing hydrofluoroalkanes and alkyl saccharides
WO1996019206A1 (en) * 1994-12-22 1996-06-27 Astra Aktiebolag Therapeutic preparation for inhalation containing parathyroïd hormone, pth
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
SE9404468D0 (sv) * 1994-12-22 1994-12-22 Astra Ab Powder formulations
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
US7771746B2 (en) * 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
ATE267582T1 (de) * 2000-01-20 2004-06-15 Basilea Pharmaceutica Ag Nasal verabreichbare cyclische antimykotische peptidzusammensetzungen
US20030008005A1 (en) * 2001-07-05 2003-01-09 R.T. Alamo Ventures, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
GB2405334B (en) * 2002-04-17 2006-02-15 Nektar Therapeutics Uk Ltd Particulate materials
KR20160106200A (ko) 2007-02-11 2016-09-09 맵 파마슈티컬스, 인코포레이티드 부작용 프로파일을 최소화하면서 편두통의 빠른 완화를 가능하게 하는 dhe의 치료적 투여 방법
US20120000941A1 (en) * 2010-06-30 2012-01-05 Inspire Pharmaceuticals, Inc. Medicine dispenser
MX2018002895A (es) 2015-09-10 2018-07-06 Impel Neuropharma Inc Dispositivo de administracion nasal en linea.
CN110831578A (zh) * 2017-07-02 2020-02-21 瑞迪博士实验室有限公司 双氢麦角胺的鼻用剂型
RU2020125871A (ru) 2018-01-05 2022-02-07 Импел Ньюрофарма, Инк. Интраназальная доставка дигидроэрготамина с помощью прецизионного устройства для доставки в обонятельную область
GB2581431A (en) * 2018-12-11 2020-08-19 Satsuma Pharmaceuticals Inc Compositions, devices, and methods for treating or preventing headaches
EP3893877A4 (en) 2018-12-11 2022-09-14 Satsuma Pharmaceuticals, Inc. COMPOSITIONS, DEVICES AND METHODS FOR TREATMENT OR PREVENTION OF HEADACHE

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1063512A (en) * 1962-11-30 1967-03-30 Benger Lab Ltd Aerosols
GB1175430A (en) * 1966-04-07 1969-12-23 Sandoz Ltd Pharmaceutical Compositions containing Ergot Alkaloids
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
CH534683A (de) * 1970-05-26 1973-03-15 Sandoz Ag Verfahren zur Herstellung neuer Mutterkornpeptidalkaloide
US4076715A (en) * 1972-09-26 1978-02-28 Sandoz Ltd. 13-Bromo lysergic acid compounds
CA990287A (en) * 1972-09-26 1976-06-01 Sandoz Patents Limited 13-bromo-lysergic acid compounds
NL7314066A (da) * 1972-10-18 1974-04-22
US3896228A (en) * 1973-03-15 1975-07-22 Sandoz Ltd Method for treating nephrises
US3883655A (en) * 1973-10-11 1975-05-13 Sandoz Ltd Ergocornine or 2-bromo-{60 -ergocyptine in the treatment of parkinsonism
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
EP0119493A1 (en) * 1983-03-16 1984-09-26 American Cyanamid Company Use of copolymers of 2-acrylamido-2-methylpropane sulfonic acid for improving retention and dewatering in the manufacture of paper

Also Published As

Publication number Publication date
NL7712552A (nl) 1978-05-23
GB1592563A (en) 1981-07-08
DK153440C (da) 1989-01-02
DE2750090A1 (de) 1978-06-01
PT67292A (fr) 1977-12-01
NL187892C (nl) 1992-02-17
SG61784G (en) 1985-03-15
DK153440B (da) 1988-07-18
FR2371454A1 (fr) 1978-06-16
HK85984A (en) 1984-11-16
SE451944B (sv) 1987-11-09
PH23643A (en) 1989-09-27
PT67292B (fr) 1979-11-12
NL187892B (nl) 1991-09-16
IL53419A0 (en) 1978-01-31
FR2371454B1 (da) 1980-08-22
AU520754B2 (en) 1982-02-25
CS228523B2 (en) 1984-05-14
DE2802113A1 (de) 1979-07-26
HU185924B (en) 1985-03-28
CY1266A (en) 1984-11-23
NZ185711A (en) 1980-04-28
IE46167B1 (en) 1983-03-09
AT368881B (de) 1982-11-25
FI773376A (fi) 1978-05-20
ES464275A1 (es) 1978-12-16
ATA825477A (de) 1982-04-15
NO773839L (no) 1978-05-22
JPS6313965B2 (da) 1988-03-29
JPS5366440A (en) 1978-06-13
IL53419A (en) 1982-04-30
CA1103585A (en) 1981-06-23
KE3453A (en) 1984-10-05
GR65229B (en) 1980-07-30
IE46167L (en) 1978-05-19
US4462983A (en) 1984-07-31
MY8400055A (en) 1984-12-31
CS228502B2 (en) 1984-04-16
US4758423A (en) 1988-07-19
SE7712693L (sv) 1978-05-20
AU3078377A (en) 1979-05-24

Similar Documents

Publication Publication Date Title
DK499477A (da) Anvendelse af ergotpeptidalkaloid-praeparat
SE7700032L (sv) Framstellning av n-fosfonometylglysin
FR2340298A1 (fr) Preparation de meta-aryloxy-benzaldehydes
DK244577A (da) Fremgangsmade til fremstilling af hydantoinderivater
TR19652A (tr) Gamma-pironlarin hazirlanmasi
DK191877A (da) Derivater af n-phosphonomethylglycin
DK577977A (da) Fremgangsmaade til fremstilling af alfa-l-aspartyl-l-phenylalanin-methyler
DK339677A (da) Fremgangsmade til fremstilling af 2-benzylpyrrolidiner
DK302578A (da) Reduktion af phosphinoxider
BE852557A (fr) Preparation de nouvelles isobutyramides
DK587077A (da) Fremgangsmaade til fremstilling af estere
DK144377A (da) Fremgangsmade til fremstilling af acylcyanider
DK517176A (da) Fremstilling af ethylchlorthioformiat
DK148786C (da) Baererlag bestaaende af vliesstof
DK510977A (da) Hygiejnisk-kosmetisk praeparat
DK216977A (da) Fremgangsmade til fremstilling af imidazobenzoxaziner
DK144277A (da) Fremgangsmade til fremstilling af acylcyanider
DK338780A (da) Phosphorestere af alkylcykloalkyl-5-pyrimidinoler
DK575277A (da) Fremgangsmaade til fremstilling af basisk substituerede 0-propyloximer
DK73277A (da) Fremgangsmaade til fremstilling af sulfonylbenzimidazoler
DK549577A (da) Fremgangsmaade til fremsitlling af oelurt
DK538977A (da) Fremgangsmaade til fremstilling af 17alfa-hydroxy-21-acetoxy-progesteron
DK582177A (da) Fremgangsmaade til fremstilling af halogenacylamider
DK196577A (da) Fremgangsmade til fremstilling af kolecystokinin-pankreozymin-oktapeptidamidsulfatester
BE856414A (fr) Preparation de trans-hexahydrodibenzopyranones

Legal Events

Date Code Title Description
PUP Patent expired